EMCC European Monitoring Centre on Change



Geographic Location

Country: World


Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number Employed: 78099
Group: Aventis

Employment Effects

Announcement Date: 08-12-2003
Type of Restructuring: Internal restructuring
Employment Effect Start: 01-01-2004

Additional Information

Aventis, the Franco-German pharmaceutical group, could close half of its production sites worldwide. As of 2004, measures will be taken in order to stimulate company growth, cutting costs by 500 million euros per year till 2006. Slowing of sales in the US market and changing health policies in France and Germany explain the financial difficulties the group is facing.